FACULTY
Dr. Fatima Alkaabi
Vice Chair, National MS Society UAE
Executive Director, Abu Dhabi Bone Marrow Transplant Program, Abu Dhabi Stem Cells Center
Abu Dhabi, United Arab Emirates
Ms. Ghalya Al Ali
Founding Member
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
Paulina Arce Casillas
Senior Organisational Development and Movement Building Manager
MS International Federation (MSIF)
London, United Kingdom
Dr. Raed Alroughani
Consultant Neurologist, Director of MS Clinic
Amiri and Ibn Sina Hospitals
Kuwait City, Kuwait
Ms. Najoua El Abkari
President, HANASEP
Rabat, Morocco
Ms. Yasmin Mitwally
Research and Advocacy Manager
National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
Ms. Zoe Burr
Head of Organisational Development and Movement Building
MS International Federation (MSIF)
Liverpool, United Kingdom
Dr. Tim Coetzee
Chief Advocacy, Services & Science Officer
US National MS Society
New York, United States of America
Ms. Joanna Laurson-Doube
International Consultant - Access to Healthcare
Hong Kong, SAR China , Hong Kong
Ms. Douna Haj Ahmed
Organisational Development and Movement Building Officer
MS International Federation (MSIF)
London, United Kingdom
Dr Ahmed Shatila
Consultant Neurologist, Chairman of Medical Advisory Committee
Sheikh Shakhbout Medical City, National Multiple Sclerosis Society UAE
Abu Dhabi, United Arab Emirates
Prof. Bassem I. Yamout
President, Professor of Neurology, Director, Neurology Institute
American University of Beirut, Harley Street Medical Center
Abu Dhabi, United Arab Emirates
Dr. Maya Zeineddine
Research Manager
Neurology Institute at Harley Street Medical Center
Abu Dhabi, United Arab Emirates
PROGRAM
09:00-10:45 | SESSION 1 | Chair: Joelle Massouh |
---|---|---|
09:00-09:10 | Welcome and Introduction | F. Alkaabi (AE) |
09:10-09:30 | Keynote: Overview of the National MS Society UAE | F. Alkaabi (AE) |
09:30-09:50 | Improving Access to Information in the UAE and the Wider Region | G. Al Ali (AE) |
09:50-10:15 | Q&A with the National MS Society UAE | Moderated by F. Alkaabi (AE) & G. Al Ali (AE) |
10:15-10:45 | Coffee Break | |
10:45-12:15 | Session II: Key Research Updates | Chair: Z. Burr (UK) |
10:45-11:15 | Overview of the Progressive MS Alliance | T. Coetzee (US) |
11:15-12:15 | Key Research Updates from the MENACTRIMS Congress 2023 | R. Alroughani (KW) |
12:15-14:00 | Lunch Break | |
14:00-15:30 | Session III: Access to MS Treatments | Chair: J. Laurson-Doube (UK) |
14:00-14:30 | MENA Access to Treatment Charter | D.H. Ahmed (UK) & P. Arce-Casillas (UK) |
14:30-15:15 | Using MSIF and MENACTRIMS Advocacy Tools | B. Yamout (AE) |
15:15-15:30 | Case Study from Lebanon: How to use the WHO EML to get access to a wider range of DMTs | M. Zeineddine (LB) |
15:30-16:00 | Coffee Break | |
16:00 - 17:00 | Session IV: Access to MS Treatments | Chair: J. Laurson-Doube (UK) |
16:00 -16:15 | Case Study from UAE: Developing National Treatment Guidelines | A. Shatila (AE) & Y. Mitwally (AE) |
16:15-16:30 | Case Study from Morocco: How to use the WHO EML to cover the cost of MS treatment by the health system | N. El Abkari (MA) |
16:30-17:00 | Q&A | Moderated by J. Laurson-Doube (UK) |
TARGET AUDIENCE
MS clinicians interested in learning more about and working with MS organisations, MS organisation representatives.